New Results
Active growth signalling promotes cancer cell sensitivity to the CDK7 inhibitor ICEC0942
G.A. Wilson, View ORCID ProfileG. Sava, View ORCID ProfileK. Vuina, View ORCID ProfileC. Huard, View ORCID ProfileL. Meneguello, View ORCID ProfileJ. Coulombe-Huntington, View ORCID ProfileT. Bertomeu, View ORCID ProfileR.J. Maizels, View ORCID ProfileJ. Lauring, View ORCID ProfileM. Tyers, View ORCID ProfileS. Ali, View ORCID ProfileC. Bertoli, View ORCID ProfileR.A.M. de Bruin
doi: https://doi.org/10.1101/2021.09.10.459733
G.A. Wilson
1MRC Laboratory for Molecular Cell Biology, University College London, United Kingdom
G. Sava
2Division of Cancer, Department of Surgery & Cancer, Imperial College London, United Kingdom
K. Vuina
1MRC Laboratory for Molecular Cell Biology, University College London, United Kingdom
C. Huard
3Department of Medicine, Faculty of Medicine, Université de Montréal, Canada
L. Meneguello
1MRC Laboratory for Molecular Cell Biology, University College London, United Kingdom
J. Coulombe-Huntington
3Department of Medicine, Faculty of Medicine, Université de Montréal, Canada
T. Bertomeu
3Department of Medicine, Faculty of Medicine, Université de Montréal, Canada
R.J. Maizels
1MRC Laboratory for Molecular Cell Biology, University College London, United Kingdom
J. Lauring
4The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, USA
M. Tyers
3Department of Medicine, Faculty of Medicine, Université de Montréal, Canada
S. Ali
2Division of Cancer, Department of Surgery & Cancer, Imperial College London, United Kingdom
C. Bertoli
1MRC Laboratory for Molecular Cell Biology, University College London, United Kingdom
R.A.M. de Bruin
1MRC Laboratory for Molecular Cell Biology, University College London, United Kingdom
5UCL Cancer Institute, University College London, United Kingdom
Article usage
Posted September 10, 2021.
Active growth signalling promotes cancer cell sensitivity to the CDK7 inhibitor ICEC0942
G.A. Wilson, G. Sava, K. Vuina, C. Huard, L. Meneguello, J. Coulombe-Huntington, T. Bertomeu, R.J. Maizels, J. Lauring, M. Tyers, S. Ali, C. Bertoli, R.A.M. de Bruin
bioRxiv 2021.09.10.459733; doi: https://doi.org/10.1101/2021.09.10.459733
Active growth signalling promotes cancer cell sensitivity to the CDK7 inhibitor ICEC0942
G.A. Wilson, G. Sava, K. Vuina, C. Huard, L. Meneguello, J. Coulombe-Huntington, T. Bertomeu, R.J. Maizels, J. Lauring, M. Tyers, S. Ali, C. Bertoli, R.A.M. de Bruin
bioRxiv 2021.09.10.459733; doi: https://doi.org/10.1101/2021.09.10.459733
Subject Area
Subject Areas
- Biochemistry (11752)
- Bioengineering (8752)
- Bioinformatics (29200)
- Biophysics (14974)
- Cancer Biology (12096)
- Cell Biology (17411)
- Clinical Trials (138)
- Developmental Biology (9421)
- Ecology (14182)
- Epidemiology (2067)
- Evolutionary Biology (18308)
- Genetics (12245)
- Genomics (16803)
- Immunology (11869)
- Microbiology (28097)
- Molecular Biology (11594)
- Neuroscience (60969)
- Paleontology (451)
- Pathology (1871)
- Pharmacology and Toxicology (3238)
- Physiology (4959)
- Plant Biology (10427)
- Synthetic Biology (2886)
- Systems Biology (7340)
- Zoology (1651)